在南非,先进性药物遗传查的案例
Tracey Hurrell1, Jerolen Naidoo1, Collen Masimirembwa2,3
1Bioengineering and Integrated Genomics Group, Future Production Chemicals Cluster, Council for Scientific and Industrial Research, Pretoria 0001, South Africa.
Journal of personalized medicine
|January 26, 2024
概括
在非洲,基因组医学的实施受到遗传多样性差的限制. 预防性药物遗传查可以减少药物不良反应,但需要针对南非人口量身定制的策略.
科学领域:
- 药物基因组学 药物基因组学
- 基因组医学是基因组医学.
- 药品安全 药品安全
背景情况:
- 全球遗传多样性的公平代表对于基因组医学至关重要,特别是在像非洲这样代表性不足的人群中.
- 多国PREPARE研究表明,基因型指导的处方可使药物不良反应 (ADR) 减少30%.
研究的目的:
- 为了比较南非的医院药房趋势与PREPARE研究中监测的药物.
- 通过检查药物基因等位基因频率和本地ADR数据,评估南非预防性药物基因查的潜在影响.
主要方法:
- 从史蒂夫·比科学术医院 (SBAH) 分析了来自PREPARE研究的29种药物的医院药房数据.
- 查询与这些药物相关的局部副作用的VigiLyze数据.
- 非洲和欧洲人群中药基因等位基因频率的比较.
主要成果:
- 29种PREPARE研究药物约占总处方的10%和SBAH总支出的9%.
- 在29种药物中,有27种涉及南非疑似,并发性或相互作用的ADR报告.
- 在非洲和欧洲人群之间,药基因等位基因频率存在显著差异.
结论:
- 预防性药物遗传查有可能减少南非的不良反应.
- 需要充分应用药物遗传查来量化其益处.
- 区域基因组多样性,疾病负担和治疗选择可以指导今天的向药物遗传学 (PGx) 实施.
相关概念视频
Genetic Screens
4.9K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
4.9K
Pharmacovigilance
833
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
833
Analysis of Population Pharmacokinetic Data
257
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
257


